Kintor Pharmaceutical Ltd
HKEX:9939
Kintor Pharmaceutical Ltd
HKEX:9939
Price:
2.73
HKD
-7.46%
Market Closed
Market Cap:
HK$1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kintor Pharmaceutical Ltd
HKEX:9939
|
CN |
|
Shinyoung Securities Co Ltd
KRX:001725
|
KR |
|
Ecomiam SA
PAR:ALECO
|
FR |
|
Indah Kiat Pulp & Paper Tbk PT
OTC:PIKQF
|
ID |
|
S
|
Sungei Bagan Rubber Company Malaya Bhd
KLSE:SBAGAN
|
MY |
|
Brasilagro Companhia Brasileira de Propriedades Agricolas
BOVESPA:AGRO3
|
BR |
|
O
|
Ozata Denizcilik Sanayi ve Ticaret AS
IST:OZATD.E
|
TR |
Income Statement
Earnings Waterfall
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd
Income Statement
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd
Currency: CNY
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
3
|
4
|
2
|
3
|
8
|
12
|
10
|
9
|
9
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
34
N/A
|
34
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
11
+120%
|
33
+198%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(44)
|
(43)
|
(10)
|
(17)
|
(25)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
34
N/A
|
34
N/A
|
0
N/A
|
0
N/A
|
(44)
N/A
|
(43)
+3%
|
(5)
+89%
|
(6)
-28%
|
8
N/A
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(400)
|
(651)
|
(869)
|
(1 070)
|
(969)
|
(652)
|
(1 026)
|
(882)
|
(150)
|
(159)
|
(209)
|
|
| Selling, General & Administrative |
(83)
|
(93)
|
(112)
|
(138)
|
(144)
|
(136)
|
(87)
|
(72)
|
(81)
|
(87)
|
(123)
|
|
| Research & Development |
(325)
|
(463)
|
(763)
|
(947)
|
(819)
|
(532)
|
(929)
|
(814)
|
(69)
|
(87)
|
(87)
|
|
| Depreciation & Amortization |
(6)
|
0
|
(10)
|
0
|
(18)
|
0
|
(19)
|
0
|
(18)
|
0
|
0
|
|
| Other Operating Expenses |
15
|
(95)
|
17
|
15
|
11
|
16
|
9
|
4
|
17
|
16
|
2
|
|
| Operating Income |
(400)
N/A
|
(651)
-63%
|
(835)
-28%
|
(1 036)
-24%
|
(969)
+6%
|
(652)
+33%
|
(1 070)
-64%
|
(924)
+14%
|
(155)
+83%
|
(165)
-6%
|
(201)
-22%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(109)
|
12
|
(7)
|
1
|
16
|
5
|
1
|
(3)
|
(3)
|
(5)
|
(3)
|
|
| Non-Reccuring Items |
1
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
3
|
2
|
1
|
|
| Pre-Tax Income |
(508)
N/A
|
(639)
-26%
|
(842)
-32%
|
(1 035)
-23%
|
(953)
+8%
|
(647)
+32%
|
(1 069)
-65%
|
(928)
+13%
|
(155)
+83%
|
(167)
-8%
|
(203)
-21%
|
|
| Net Income | ||||||||||||
| Tax Provision |
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
8
|
8
|
(0)
|
0
|
3
|
|
| Income from Continuing Operations |
(508)
|
(639)
|
(842)
|
(1 035)
|
(954)
|
(648)
|
(1 061)
|
(920)
|
(155)
|
(167)
|
(200)
|
|
| Net Income (Common) |
(508)
N/A
|
(639)
-26%
|
(842)
-32%
|
(1 035)
-23%
|
(954)
+8%
|
(648)
+32%
|
(1 061)
-64%
|
(920)
+13%
|
(155)
+83%
|
(167)
-8%
|
(200)
-20%
|
|
| EPS (Diluted) |
-1.64
N/A
|
-1.84
-12%
|
-2.36
-28%
|
-2.84
-20%
|
-2.53
+11%
|
-1.51
+40%
|
-2.47
-64%
|
-2.14
+13%
|
-0.36
+83%
|
-0.39
-8%
|
-0.44
-13%
|
|
Switch to:
Switch to:
See Also
Discover More
